Welcome, Sign In
AstraZeneca Says 'No Thanks' to Pfizer
Description:AstraZeneca rejected an improved takeover offer from Pfizer worth more than $106 billion, saying the proposal substantially undervalued the company. WSJ's Dana Cimilluca joins MoneyBeat with the details. Photo: Getty.
pfizer astrazeneca deal
pfizer astrazeneca merger offer
pfizer bid for astrazeneca